1. Home
  2. PARR vs BLLN Comparison

PARR vs BLLN Comparison

Compare PARR & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Par Pacific Holdings Inc.

PARR

Par Pacific Holdings Inc.

HOLD

Current Price

$65.28

Market Cap

3.2B

Sector

Energy

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$76.16

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PARR
BLLN
Founded
1984
2016
Country
United States
United States
Employees
N/A
713
Industry
Integrated oil Companies
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.9B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
PARR
BLLN
Price
$65.28
$76.16
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$70.17
$126.71
AVG Volume (30 Days)
1.3M
372.4K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
1313.56
N/A
EPS
7.16
N/A
Revenue
$2,443,066,000.00
N/A
Revenue This Year
N/A
$46.29
Revenue Next Year
$3.78
$30.14
P/E Ratio
$9.17
N/A
Revenue Growth
30.99
N/A
52 Week Low
$14.01
$61.96
52 Week High
$68.00
$138.70

Technical Indicators

Market Signals
Indicator
PARR
BLLN
Relative Strength Index (RSI) 57.79 45.20
Support Level $34.55 $64.99
Resistance Level $67.39 $83.20
Average True Range (ATR) 3.13 6.09
MACD -0.13 -1.22
Stochastic Oscillator 80.93 23.02

Price Performance

Historical Comparison
PARR
BLLN

About PARR Par Pacific Holdings Inc.

Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments: Refining. Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operating licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: